PharmaResearch Co., Ltd. (KOSDAQ:214450)

South Korea flag South Korea · Delayed Price · Currency is KRW
302,000
+5,000 (1.68%)
Apr 10, 2026, 3:30 PM KST
Market Cap3.09T -8.9%
Revenue (ttm)536.29B +53.2%
Net Income165.12B +79.4%
EPS14,933.00 +67.0%
Shares Out10.39M
PE Ratio19.89
Forward PE15.20
Dividend3,700.00 (1.26%)
Ex-Dividend DateDec 29, 2025
Volume43,638
Average Volume63,058
Open303,500
Previous Close297,000
Day's Range298,500 - 304,500
52-Week Range278,500 - 713,000
Beta0.62
RSI45.09
Earnings DateMay 8, 2026

About PharmaResearch

PharmaResearch Co., Ltd., together with its subsidiaries, operates as a biopharmaceutical company primarily in South Korea. The company offers Re-An eye drops for protecting eyes from corneal damages with various causes; JBP PLAMON injection, a brown ampoule containing a pale yellow transparent liquid; ZADAXIN injection, an adjunctive therapy for influenza vaccination in immunocompromised elderly patients; PLACENTEX injection for the treatment and tissue restoration of wounds; CLEVIEL VOLUME to temporarily improve facial wrinkles in adults thro... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1993
Employees 497
Stock Exchange KOSDAQ
Ticker Symbol 214450
Full Company Profile

Financial Performance

In 2025, PharmaResearch's revenue was 536.29 billion, an increase of 53.18% compared to the previous year's 350.12 billion. Earnings were 165.12 billion, an increase of 79.39%.

Financial Statements